3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
51
Neoplasms
45
Colorectal Neoplasms
27
Carcinoma, Non-Small-Cell Lung
22
Prostatic Neoplasms
20
Lung Neoplasms
16
Leukemia, Myeloid, Acute
16
Recurrence
12
Multiple Myeloma
11
Melanoma
11
Stomach Neoplasms
10
Head and Neck Neoplasms
10
Ovarian Neoplasms
9
Uterine Cervical Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, Non-Hodgkin
8
Pancreatic Neoplasms
7
Neoplasm Metastasis
7
Myelodysplastic Syndromes
7
Lymphoma
7
Glioma
7
Carcinoma, Renal Cell
7
Brain Neoplasms
7
Motor Activity
6
Leukemia
6
Hodgkin Disease
6
Esophageal Neoplasms
6
Colonic Neoplasms
6
Carcinoma, Hepatocellular
6
Interventions
vinflunine
1
sacituzumab govitecan
1
Paclitaxel
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Locally Advanced or Metastatic Unresectable Urothelial Cancer
×
30 days
×
Clear all
NCT04527991
2026-06-02
TROPiCS-04
Gilead Sciences
Phase 3
Completed
711 enrolled
25 charts